
pmid: 20483608
A novel series of pyrazolo[1,5a]pyrimidines was optimized to target lymphocyte-specific kinase (Lck). An efficient synthetic route was developed and SAR studies toward activity and selectivity are described, leading to Lck inhibitors with enzymatic, cellular and in vivo potency.
Administration, Oral, Lymphocyte Activation, Rats, Mice, Structure-Activity Relationship, Pyrimidines, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Microsomes, Liver, Animals, Humans, Interleukin-2
Administration, Oral, Lymphocyte Activation, Rats, Mice, Structure-Activity Relationship, Pyrimidines, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Microsomes, Liver, Animals, Humans, Interleukin-2
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 23 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
